The composition of the mitochondrial inner membrane and uncoupling protein such as adenine nucleotide translocator (ANT) contents are the main factors involved in the energy wasting proton leak. We have shown that this leak was increased by glucocorticoid treatment under non phosphorylating conditions. The aim of this study was to investigate mechanisms involved in glucocorticoid-induced proton leak and to evaluate the consequences in more physiological conditions (between states 4 and 3).
Introduction
Glucocorticoid hormones are known to regulate various biological functions such as the carbohydrate, protein and fat metabolism (28) . Glucocorticoid treatment, particularly with dexamethasone, induces a hypercatabolic state characterized by accelerated protein turnover in skeletal muscle and gluconeogenesis in the liver, leading finally to augmented energy expenditure. Indeed, dexamethasone administration in healthy humans is associated with an increase in the resting energy expenditure (5, 16, 22, 29) , which corresponds to a higher oxygen consumption at the whole body level. We have suggested that the increased energy expenditure may be linked to the effect of glucocorticoids on mitochondria (8, 27, 28) . Since 20% of the resting metabolism is due to futile proton cycles across the inner mitochondrial membrane (26) , we focused on the proton leak and recently reported that dexamethasone treatment increases non-phosphorylating respiration (8) and basal proton conductance (27) in rat liver mitochondria. Roussel et al. have estimated that these phenomena explain a 3% increase in whole-body oxygen consumption.
The exact mechanism of basal proton conductance in mitochondria is not completely understood. Many studies have reported consistent correlations between proton conductance and the inner-membrane surface area or the phospholipid composition in mitochondria from different tissues and different species (23, 12, 7) . A close relationship has also been established between the basal proton leak and the adenosine nucleotide translocator (ANT) content (3) . Taking these findings into account, we were led to hypothesize that dexamethasone promotes the proton leak by increasing the mitochondrial ANT content.
In non physiological conditions, such as saturating ADP concentrations, dexamethasone is known to lower the ATP/O ratio (15, 17, 19) and may reduce the efficiency of mitochondrial oxidative phosphorylation (28) . However, mitochondria usually work between state 4 and state 3, conditions that have never been investigated in previous studies. This can be assessed by generating different steady states of ADP concentrations with hexokinase titration. By using such an approach, we conclude that in this more physiological state, mitochondria from dexamethasone treated rats exhibit a higher capacity for ATP production. This is probably achieved by an increase in both ANT and ATP synthase content.
Materials and methods

Reagents and standards
Chemicals and reagents were purchased from Sigma Aldrich (Saint Quentin Fallavier, France) except for Tris and Tris-HCL, which were obtained from Eurobio (Les Ulis, France).
Triphenylmethylphosphonium and methanol were purchased from Merck (VWR International, Strasbourg, France); BSA and NADH from Roche-Boehringer (Meylan, France); bicinchoninic acid assay kit and phospholipids standards from Interchim (Montluçon, France); and chloroform and hexane from Prolabo (Fontenay-sous-Bois, France).
Animals
All investigations were performed according to the guidelines for the care and use of animals laid down by the French Department of Animal and Environmental Protection.
Sixteen male Sprague-Dawley rats, born and bred in our animal facilities, were housed in individual cages from the age of 13 weeks (330-400g). Animals were provided with water ad libitum and a standard diet (U-A-R A04) composed of (% total weight) 16% protein, 3% fat, 60% carbohydrate and 21% water, fiber, vitamins and minerals. The metabolisable energy content was 2.9 kcal/day. Rats were randomly allocated into 2 groups (8 rats per group) as follows: the control group (CON) and the dexamethasone-treated group (DEXA).
Dexamethasone-treated rats received a daily intraperitoneal injection of 1.5 mg/kg of Page 4 of 22 dexamethasone for 5 days. All rats were fasted during the night following the fifth day. On the sixth day, the animals were killed by decapitation.
Preparation of liver mitochondria
Liver mitochondria were prepared as previously described (21) in a medium containing 100 mM sucrose, 50 mM KCl, 5 mM EGTA and 50 mM Tris/Hcl, pH 7.4. Protein concentrations were determined by using the bicinchoninic acid assay kit (Interchim, Montluçon, France) with bovine serum albumin used as a standard.
Mitochondrial respiration, membrane potential and ATP synthesis
Oxygen consumption and membrane potential were measured simultaneously in a closed, stirred Perspex chamber fitted with a Clark oxygen electrode (Rank Brothers, Cambridge, England) and an electrode sensitive to the potential-dependent probe triphenylmethylphosphonium (TPMP). Mitochondria (0.5 mg protein/ml) were incubated in a respiratory reaction medium consisting of 120 mM KCl, 5 mM KH 2 PO 4 , 1 mM EGTA, 2 mM MgCl 2 , 5 OM rotenone, 80 ng/ml nigericin, 3 mM hepes (pH 7.4, 30°C) supplemented with 0.3% (w/v) bovine serum albumin, and saturated with room air. The TPMP electrode was calibrated by sequential 0.5 OM additions up to 2 OM TPMP, after which 5 mM succinate was added to start the reaction. After each run, 2 OM of carbonyl cyanide ptrifluoromethoxyphenylhydrazone (FCCP) were added to dissipate the membrane potential and release all the TPMP back into the medium for baseline correction, if needed. Membrane potentials were calculated as previously described (25) , assuming a TPMP binding correction of 0.42 (Ol/mg of protein) -1 for liver mitochondria (26) .
The proton leak kinetics was established by carrying out titrations with nonphosphorylating mitochondria. The respiration and the inner membrane potential were progressively inhibited through successive steady states induced by the addition of malonate (up to 5 mM) in the presence of oligomycin (3 Og/ml).
In phosphorylating mitochondria, the kinetic response of substrate oxidation and the ATP/O ratio were measured in the respiratory reaction medium supplemented with 20 mM glucose and 125 OM ATP, with increasing concentrations of hexokinase ranging from 0.01 to 0.225 U/ml, in the absence of oligomycin.
Mitochondrial enzyme activities
The activity of citrate synthase was measured in a reaction medium consisting of 100 mM Tris/HCl, 40 µg/ml 5,5R-dithio-bis(2-nitrobenzoic acid), 1 mM oxaloacetate, 0.3 mM acetyl CoA and 4% of Triton X 100, pH 8.1. After 3 min of incubation, the reaction was initiated by adding the homogenate (20 to 50 µg proteins), and the change in optical density at 412 nm was recorded for 3 min.
Fractionation of mitochondria using Percoll gradients
For lipid analysis and to avoid contamination with broken plasma membrane or endoplasmic reticulum, a portion of the isolated mitochondria was further fractionated on a discontinuous Percoll gradient (60, 30 and 18% Percoll). Mitochondria were charged on the top of the gradient and centrifuged at 8700g for 1 hour. After centrifugation, mitochondria were collected at the interface 30-60% and washed 2 times with an isolation buffer (10 000g for 10 min). The pellet was dissolved in a small volume of the isolation buffer and stored at -80°C. Whole mitochondria from the Percoll gradient isolations were used to determine the mitochondrial phospholipid and fatty acid composition.
Preparation of samples for lipid analysis
Lipids were extracted by the method of Folch et al. (10) . Briefly, 5 mg of mitochondrial protein were extracted with a mixture of CHCl 3 /MeOH (1/2 v/v) containing 0.005% butylated hydroxyl-toluene (BHT) to avoid the peroxidation of polyunsaturated fatty acids. After being vortex-mixed, 1 ml of water was added to the mixture, which was again vortex-mixed and allowed to stand at room temperature for 1 hour before centrifugation at 500g for 10 min. The organic layer was then collected and the pellet was re-extracted. All the organic layers were pooled and dried in a solvent evaporator. The dry material was dissolved in 500Ol of CHCl 3 /MeOH (2/1, v/v) and stored at -80°C awaiting analysis.
Identification of phospholipids by high-performance thin-layer chromatography (HPTLC)
HPTLC plates were used after prewashing with a mixture of chloroform-methanol 15 min to stain all the phospholipids, which were finally identified by reference to standards.
Western Blotting
Equal amounts of mitochondrial proteins (15Og) from each sample (CON and DEXA rats, n=8) were boiled in the loading buffer and resolved by 12.5% SDS polyacrylamide gels. 
Statistical analysis
All results are expressed as mean values ± SEM. All comparisons between dexamethasone-treated rats and controls were made using the Mann-Whitney test. A value of p 0.05 was considered significant in all cases. The statistical analyses were performed using SPSS for Windows, Version 13.0 (Chicago, IL, USA).
Results
Mitochondrial membrane potential and oxygen consumption in state-4 respiration Figure 1 shows the relationship between oxygen consumption and the mitochondrial membrane potential in the non-phosphorylating condition. The generation of a given membrane potential required greater oxygen consumption in dexamethasone-treated (DEXA) rats than in controls (CON). Thus, for a membrane potential of 190 mV, the oxygen consumption was significantly higher in DEXA than in CON rats (23.4±7.4 vs. 17.8±2.8
natoms O/min.mg protein; p<0.05).
Mitochondrial membrane potential and oxygen consumption between state 4 and state 3 of respiration
The relationship between the mitochondrial membrane potential and oxygen consumption was linear for DEXA as well as CON rats ( Figure 2) ; the mitochondrial membrane potentials were significantly lower in DEXA than in CON rats. to approximatively 90% of the classical state 3), ATP synthesis is significantly higher in DEXA treated rats than in CON rats (p<0.05). There was a slight increase (but not significant) in oxygen consumption and ATP synthesis in DEXA rats for the other values of hexokinase concentrations. However, no differences in ATP/O ratio were observed between DEXA rats and CON rats at any hexokinase addition value.
Mitochondrial citrate synthase activity
There was no difference in citrate synthase activity between DEXA and CON rats (294.4 ±45.1 vs. 323.0 ±85.4 nmol/min/mg of protein).
Mitochondrial phospholipid composition
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Our results show that neither the mitochondrial phospholipid content nor the phospholipid composition was modified by dexamethasone treatment ( Table 1 ). The total amount of phospholipid (expressed as mg of mitochondrial protein), was also unaffected by the treatment (0.146 ±0.054 vs. 0.128 ±0.024 mg of total phospholipids/mg of protein for DEXA and CON rats, respectively). This suggests a similarity of the mitochondrial membrane surface area in DEXA and CON rats.
Analysis of the ATP synthase /-subunit and ANT content by Western blotting
The relative content of the ATP synthase U-subunit protein ( 
Discussion
This study gives evidence for a direct impact of glucocorticoids on the efficiency of oxidative phosphorylation. We have previously shown that dexamethasone treatment in rats increased the proton leak (27) . In the present study, we confirm this result and show that in more physiological conditions, i.e. between state 4 and state 3, the ATP synthesis was significantly higher in DEXA than in CON rats. We also found that the ANT and the ATP synthase U-subunit contents were significantly increased by the dexamethasone treatment.
We recently reported that the basal proton conductance of the mitochondrial inner membrane is very different in liver mitochondria of rats given glucocorticoids (8, 27) . Among the factors known to affect proton conductance there is the phospholipid composition of the membrane (2, 4, 13) . Many correlative studies comparing mitochondria from different tissues in different species with various thyroid hormonal states have demonstrated the importance of the mitochondrial inner membrane surface area and the phospholipid composition as determinants of the basal proton leak (6, 7). In our study, the evaluation of these factors was performed on whole mitochondria isolated on Percoll gradients assuming that, at least in the rat liver, the phospholipid content of whole mitochondria reflects the composition of the inner membrane. Our results clearly indicate that the dexamethasone treatment modifies neither the membrane surface area nor the phospholipid composition of mitochondria. Natural differences in basal proton conductance also correlate with differences in the fatty acyl composition of phospholipids and dexamethasone has been reported to depress delta-6-and delta-5-desaturase while increasing delta-9-desaturase in the liver. However, it is unlikely that the increased proton leak we observed in dexamethasone-treated rats was the result of modification of the fatty acid composition. The proton permeability of liposomes made from mitochondrial inner membrane phospholipids is almost unaffected by the phospholipid fatty acid composition and the main effects of dexamethasone, i.e. the increase in oleic acid and the decrease in arachidonic acid, are generally associated with low proton conductance.
Nevertheless, we cannot totally exclude the possibility that dexamethasone treatment may specifically modify the acyl composition of some classes of phospholipids. This point needs to be addressed in further studies.
Brand et al. recently stated that there is a striking correlation between mitochondrial proton leak and ANT content of the mitochondrial inner membrane and suggested that ANT is a major catalyst of the basal fatty-acid independent proton leak in mitochondria (3). We found that the dexamethasone treatment increased the ANT content; in fact, the dexamethasonetreated rats showed a 100% increase in the ANT content compared to controls. This indicates that the increased ANT content is a major factor in increasing the mitochondrial proton leak in dexamethasone-treated rats. The shift to the left of the non-ohmic part of the Nichol's curve confirms that mitochondria from dexamethasone treated rats display an increase in proton leak. This accounts for the increase in state 4 respiratory rates together with the decrease in protonmotive force we previously reported (8, 27) . However, the ohmic part of the curve is clearly not affected. This led us to exclude a single protonophoric effect of the increased ANT content (24) . Moreover as discussed below, the greater ANT content does not deteriorate the efficiency of such mitochondria since control and dexamethasone treated rats exhibit similar ATP/O ratios, while the protonmotive forces are quite different (cf. figure 2) . This clearly indicates that in phosphorylating conditions, the energy wastage (proton leak and/or redox slip) is comparable in dexamethasone treated rats and in control rats.
Many studies (15, 17 and 20) showed that dexamethasone administration lowers ATP/O ratio. In our present study, we found no significant differences in ATP/O ratio between CON and DEXA rats. This discrepancy is explained by the fact that ATP/O ratios were not assessed the same way. In the previous studies, P/O ratios were only measured using a saturating concentration of ADP. In our present study, ATP/O ratios were measured using a non-saturating ADP generating system based on hexokinase, which is more physiological.
This means that we can be trustfull on the fact that the ATP/O ratios are not significantly different between dexamethasone treated rats and control rats under physiological respiratory state (between state 4 and state 3). Furthermore, ATP/O ratios are different between these two rat groups for higher oxygen consumption with the ADP saturating method (15, 17, 20 and 28) .
Since the ANT translocates ADP in the mitochondrial matrix, the higher ANT content is likely to increase the ADP flux, thereby enhancing the rate of oxidative phosphorylation (18 directly linked to the efficiency of mitochondrial ATP synthesis (12, 13) . These results show that dexamethasone improves ATP synthesis in rat mitochondria ( Figure 4 and Table 1 ).
Taken together, these results indicate that dexamethasone treatment increases the capacity of rat liver mitochondria to phosphorylate ATP.
Glucocorticoid treatment increases gluconeogenesis, lipolysis and proteolysis (1, 5, 9, 16, and 30) . These pathways are large-scale consumers of ATP. Our results suggest that the mitochondrial response to ATP requirements is an increase in both the ADP input capacity and of ATP output capacity mediated by ANT. However, the higher ANT content may have a side effect: the increase in the basal proton leak under state 4 of respiration.
Proton leak explains 20% of the whole-body oxygen consumption (25) . An increase in proton leak probably increases oxygen consumption (estimated to 3%) at the whole-body level (27) . Between state 4 and state 3, mitochondrial oxygen consumption is mildly increased in order to support higher ATP synthesis. Taken together, since mitochondria contributes to 90% of the whole-body oxygen consumption, dexamethasone induced changes in mitochondrial metabolism that participate to the increase in resting energy expenditure.
In conclusion, the present study shows that under physiological conditions, mitochondria of dexamethasone treated rats improve their ATP production efficiency.
Increased ANT and ATP synthase membrane contents may participate to this improvement, the side effect being an increased proton leak under state 4. The blot was then probed with peroxidase-conjugated rabbit anti-mouse IgG. Signals were visualized on high-performance chemiluminescence film using the enhanced chemoluminescence procedure (* p<0.01). Table 2 Control DEXA Cardiolipin 12.2 ± 2.1 12.9 ± 3.8 Phosphoethanolamine 30.4 ± 2.7 31.2 ± 2.9
Phosphatidylcholine 57.4 ± 3.6 55.9 ± 4.7
Phospholipid content (%)
Rats
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